Tag: body weight

Burlingame, CA, July 02, 2025 (GLOBE NEWSWIRE) -- The global automotive bumper market is estimated to be valued at USD 21.27 Bn in 2025 and is expected to reach USD 28.37 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2025 to 2032. The growth of the automotive bumper market is driven by the increasing global production of automobiles. Rising concerns over passenger safety are further fueling demand for automotive bumpers. Additionally, advancements in bumper design and materials aimed at improving aesthetics and enhancing damage resistance during low-speed collisions are expected to support market expansion. The rising sales of electric vehicles, along with a focus on reducing vehicle body weight, are also set to create new opportunities for lightweight bumpers in the market.

Bagsværd, Denmark, 22 June – Today, The New England Journal of Medicine (NEJM) published results from Novo Nordisk’s phase 3 REDEFINE 1 trial evaluating the efficacy and safety of investigational CagriSema plus lifestyle interventions for weight loss in adults with obesity or overweight who have a weight-related medical complication and without diabetes.¹ REDEFINE 1 met its co-primary endpoints and achieved statistically significant and clinically meaningful weight loss at 68 weeks in patients taking CagriSema versus placebo.¹ These data, along with the related phase 3 REDEFINE 2 study conducted in adults with overweight or obesity and type 2 diabetes, were presented today during a scientific symposium at the American Diabetes Association’s (ADA) 85th Scientific Sessions and published in NEJM.